Context Therapeutics Inc. (CNTX)
↓ Download CSVKey ratios (FY2025)
-59.7%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$39.70M | -$29.92M | -$25.07M | -$15.38M | -$10.53M | -$2.57M | — |
| Net Income | -$36.12M | -$26.73M | -$23.96M | -$14.84M | -$10.46M | $6.64M | — |
| EPS (Diluted) | $-0.38 | $-0.46 | $-1.50 | $-0.93 | $-3.69 | $-3.96 | — |
| Total Assets | $68.49M | $98.13M | $16.06M | $37.97M | $51.31M | $467.3K | — |
| Total Liabilities | $8.02M | $2.86M | $4.19M | $3.21M | $3.03M | $9.62M | — |
| Shareholders' Equity | $60.47M | $95.27M | $11.87M | $34.76M | $48.27M | -$16.92M | -$23.96M |
| Cash & Equivalents | $66.00M | $94.43M | $14.45M | $35.50M | $49.64M | $290.7K | — |
| Operating Cash Flow | -$26.39M | -$14.56M | -$21.05M | -$13.55M | -$8.80M | -$1.03M | — |
| Capital Expenditures | $33.9K | $7.3K | $0 | $36.8K | $0 | — | — |
| Shares Outstanding | 91.88M | 89.70M | 15.97M | 15.97M | 15.97M | 331.8K | — |